Skip to main content
Antibiotice S.A. logo

Antibiotice S.A. — Investor Relations & Filings

Ticker · ATB ISIN · ROATBIACNOR9 LEI · 315700P5G4O1L6GLMS02 RO Manufacturing
Open in API
Filings indexed 253 across all filing types
Latest filing 2026-05-21 Capital/Financing Update
Country RO Romania
Listing RO ATB

About Antibiotice S.A.

https://www.antibiotice.ro/en/

Antibiotice S.A. is a pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines for human use. The company is a significant producer of anti-infective drugs, with a portfolio that includes injectable penicillins like ampicillin and nafcillin, as well as the active pharmaceutical ingredient (API) Nystatin. It operates eight GMP-certified manufacturing lines and holds US Food and Drug Administration (FDA) approval for key products, underscoring its commitment to global quality standards. The company's mission is to make valuable medicines more accessible to patients, physicians, and pharmacists by providing affordable treatments. Its product range also extends to supplements and skincare products.

Recent filings

Filing Released Lang Actions
Raport curent de informare a investitorilor
Capital/Financing Update Classification · 85% confidence The document is a current report (‘Raport Curent’) filed on the Bucharest Stock Exchange by Antibiotice S.A., announcing a new €67 million financing from Banca Transilvania to support strategic investment projects. It is not an earnings release, interim report, or management presentation, nor is it a regulatory certification or attestation. Instead, it details a capital raise/financing arrangement, matching the Capital/Financing Update category (CAP).
2026-05-21 Romanian
Raport curent de informare a investitorilor
Regulatory Filings Classification · 80% confidence The document is a Romanian ‘Raport Curent’ announcing an upcoming teleconference to present Q1 2026 financial results. It does not include any financial data itself, nor the actual presentation materials or transcript—merely a regulatory notice of the event. It therefore falls under general regulatory announcements (fallback category), not an earnings release, transcript, or investor presentation.
2026-05-18 Romanian
Raport curent de informare a investitorilor
Regulatory Filings Classification · 60% confidence The document is a “Raport curent” (current report) issued on the Bucharest Stock Exchange, providing an update on a consulting agreement with the European Investment Bank for corporate governance advice. It is not a full financial report, earnings release, management or investor presentation, or any other highly specific filing. It serves as a general regulatory announcement with no substantive financial statements or voting results. Therefore, it falls under the fallback category of Regulatory Filings (RNS).
2026-05-13 Romanian
Raport curent de informare a investitorilor
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a current report (‘Raport Curent’) detailing the resolutions (‘Hotărârile’) of both the Ordinary and Extraordinary General Meetings of Shareholders held on 29.04.2026. It lists vote percentages and the outcomes of each shareholder vote. This matches the definition of Declaration of Voting Results (DVA) – official results from shareholder votes at a general meeting.
2026-04-29 Romanian
Convocarea adunarii generale a actionarilor - RC11
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a formal notice (“Convocarea Adunării Generale Ordinare a Acționarilor”) for Antibiotice S.A.’s Ordinary General Meeting of Shareholders including the agenda, voting procedures, proxy forms, and related materials. It is not the meeting results or the full annual report, but rather the solicitation of proxies and provision of information for shareholder voting. This aligns with “Proxy Solicitation & Information Statement (PSI).”
2026-04-23 Romanian
Raport curent de informare a investitorilor
Report Publication Announcement Classification · 85% confidence The document is a "Raport curent" from Antibiotice S.A. announcing that the Q1 2026 key performance indicators report has been prepared in accordance with OUG 109/2011 and is available on the company's website. It does not include the report content itself but merely provides notice of its availability and the date when financial results will be presented. This matches the definition of a Report Publication Announcement (RPA).
2026-04-21 Romanian

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.